Utah Medical Products stock trades at EUR 67.00 before quarterly results

Published on 10/20/2026 at 14:00 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Utah Medical extended its offer to October 27, 2026 for 650,000 shares at USD 75.00. Utah Medical Products stock trades at EUR 67.00 on October 20, 2026.

Tender terms and earnings dates

Utah Medical Products extended its offer on October 5, 2026 for 650,000 shares at USD 75.00.
First-half 2026 revenue fell 12.3 percent to USD 17.3 million, while operating margin reached 30.2 percent.
Utah Medical Products stock trades at EUR 67.00 at 1:51 p.m. CEST at Lang & Schwarz on October 20, 2026.
Third-quarter results are scheduled for October 22, 2026, and the tender deadline is October 27, 2026.

UTMD, US9174881089, Illustration mit AI erstellt.

Utah Medical Products (US9174881089) stock trades at EUR 67.00 at Lang & Schwarz on October 20, 2026, while the company is approaching two important dates for shareholders. On October 5, 2026, Yahoo Finance reported that Utah Medical extended its tender offer deadline to October 27, 2026.

Offer terms set a fixed reference

The offer covers up to 650,000 common shares at USD 75.00 per share. The extension also gives shareholders time to consider the company's calendar third-quarter results scheduled for October 22, 2026, while the other offer conditions remain unchanged, according to StockTitan.

The tender price sits beside a softer operating backdrop. For the first half of 2026, revenue fell 12.3 percent to USD 17.3 million, while operating income declined 17.9 percent to USD 5.2 million. The same period produced a 30.2 percent operating margin and a 30.7 percent net margin, Yahoo Finance reported.

What does the tender mean for earnings?

The answer depends on whether the upcoming results show stabilization after customer-related revenue pressure. First-half operating cash flow was USD 4.5 million, gross margin improved to 58.2 percent from 56.6 percent a year earlier, and cash and investments stood at USD 87.5 million on June 30, 2026. Those figures give the tender offer a measurable balance-sheet context, but they do not determine how many shares will be accepted.

Three dates frame the story

On August 4, 2026, Utah Medical announced a quarterly dividend of USD 0.31 per share, according to Yahoo Finance. On September 24, 2026, the company launched the USD 75.00 tender for 650,000 shares, as reported by Investing.com.

On October 5, 2026, the deadline moved to October 27, 2026. The next two dates are October 22, 2026, for calendar third-quarter results, and October 27, 2026, for the extended tender deadline.

Price meets a near-term catalyst

Utah Medical Products develops and markets specialty medical devices, with particular exposure to health care for women and babies. Its common stock trades on the Nasdaq Global Market under ticker UTMD, according to the company's Utah Medical Products investor-relations page.

The stock was trading at EUR 67.00 at Lang & Schwarz on October 20, 2026, at 1:51 p.m. CEST. The next earnings release and the tender deadline provide the clearest dated checkpoints for interpreting that quotation. The further course of trading is shown by the continuously updated real-time quote of Utah Medical Products stock.